budesonide inhaled/formoterol/glycopyrrolate inhaled (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

Chronic Obstructive Pulmonary Disease

Pending FDA approval for maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD)

Next:

Pharmacology

Mechanism of Action

Budesonide: Anti-inflammatory corticosteroid; has potent glucocorticoid activity and weak mineralocorticoid activity

Formoterol: Long-acting selective beta-2 agonist with rapid onset of action; acts locally as bronchodilator; stimulates intracellular adenyl cyclase, which results in increased cyclic adenosine monophosphate levels, causing relaxation of bronchial smooth muscle and inhibition of release of mast cell mediators

Glycopyrrolate: Long-acting muscarinic antagonist (LAMA); often referred to as an anticholinergic; produces bronchodilation by inhibiting acetylcholine’s effect on muscarinic receptors in the airway smooth muscle

Previous
Next:

Images

Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.